期刊论文详细信息
BMC Infectious Diseases
Predictive value of pentraxin-3 on disease severity and mortality risk in patients with hemorrhagic fever with renal syndrome
Hong Du1  Haifeng Hu1  Ying Zhang1  Jing Li1  Pingzhong Wang1  Jianqi Lian1  Xiaoyan Wang1  Hong Jiang1  Xuefan Bai1 
[1] Center for Infectious Diseases, Second Affiliated Hospital of Air Force Medical University, 569 Xinsi Rd, Baqiao District, 710038, Xi’an, Shaanxi, China;
关键词: Hemorrhagic fever with renal syndrome;    Pentraxin-3;    Early prediction;    Prognosis;    Disease severity;   
DOI  :  10.1186/s12879-021-06145-0
来源: Springer
PDF
【 摘 要 】

BackgroundHemorrhagic fever with renal syndrome (HFRS) caused by Hantaan virus is characterized by systemic immunopathological injury. Pentraxin-3 is an acute-phase reactant involved in the processes of inflammation and infection. This study aimed to investigate the levels of plasma pentraxin-3 and evaluate its predictive value on disease severity and mortality risk in patients with HFRS.MethodsThis was a prospective real-world observational study. The concentrations of plasma pentraxin-3 were measured by enzyme linked immunosorbent assay (ELISA) in 105 HFRS patients and 27 healthy controls. We analyzed the clinical relevance between pentraxin-3 and clinical subtyping, hospital stay and conventional laboratory parameters of HFRS patients. Considering the prognosis (death) as the primary endpoint, the levels of pentraxin-3 between survivors and non-survivors were compared, and its association with mortality was assessed by Kaplan-Meier survival analysis. The predictive potency of pentraxin-3 for mortality risk in HFRS patients was evaluated by receiver operating characteristic (ROC) curve analysis.ResultsThe levels of pentraxin-3 during the acute phase were increased with the aggravation of the disease, and showed the highest expression in critical-type patients (P < 0.05). Pentraxin-3 demonstrated significant correlations with conventional laboratory parameters (WBC, PLT, AST, ALB, APTT, Fib) and the length of hospital stay. Compared with the survivors, non-survivors showed higher levels of pentraxin-3 and worse expressions of conventional laboratory parameters during the acute phase. The Kaplan-Meier survival curves showed that high levels of pentraxin-3 during the acute phase were significantly associated with the death in HFRS patients. Pentraxin-3 demonstrated significant predictive value for the mortality risk of HFRS patients, with the area under ROC curve (AUC) of 0.753 (95%CI: 0.593 ~ 0.914, P = 0.003).ConclusionsThe detection of plasma pentraxin-3 might be beneficial to the evaluation of disease severity and to the prediction of mortality risk in HFRS patients.

【 授权许可】

CC BY   

【 预 览 】
附件列表
Files Size Format View
RO202107070358235ZK.pdf 1422KB PDF download
  文献评价指标  
  下载次数:9次 浏览次数:9次